Table 4.
Carriers | Noncarriers | ||||
---|---|---|---|---|---|
MelaPRO- HBI |
MelaPRO- HBI |
MelaPRO- HBI |
MelaPRO- HBI |
Reclassication | |
Pr ≥.5 | Pr < .5 | Pr ≥ .5 | Pr < .5 | Rate** | |
MelaPRO-GEM | |||||
≥.5 | 16 | 1‡ | 7 | 6† | |
<.5 | 0† | 5 | 0‡ | 160 | 4% |
MELPREDICT | |||||
≥.5 | 4 | 0‡ | 3 | 2† | |
< .5 | 12† | 6 | 4‡ | 164 | 9% |
FH | |||||
+ | 16 | 1‡ | 7 | 66† | |
− | 0† | 5 | 0‡ | 100 | 34% |
MelaPRO-LBI is not included, as the study population does not apply.
Denotes a category where MelaPRO-HBI correctly classifies as compared to other methods.
The grey shading denotes a category where MelaPRO-HBI classifies differently as compared to other methods.
Reclassification rate is defined as the percentage of individuals that were classified differently by MelaPRO-HBI (categories † and ‡) as compared to the other models